Abiopharma

🔍 ASEN R SCOTT (Executive)

Company: DURECT CORP (DRRX)

Report Date: 2025-08-22

Detailed Transactions and Holdings:

• Acquired 5,917 shares of Common Stock at $1.9194 per share (Direct)
  Date: 2025-08-22 | Code: P | equity_swap_involved: 0 | shares_owned_after: 2,672,529.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-22 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 970,000.00 | Footnotes: F1

Footnotes:

• F1: The reporting person is deemed to be the beneficial owner of 30,000 shares of Common Stock of The Asen Foundation (the "Foundation") by virtue of being a Trustee of the Foundation and possessing investment authority for the Foundation. The reporting person is deemed to be the beneficial owner of 940,000 shares of Common Stock as President of Asen & Co which provides certain advisory services to managed accounts of Asen & Co., which advisory services include the power to vote and dispose of the shares of Common Stock. The reporting person disclaims beneficial ownership of the shares held indirectly except to the extent of his pecuniary interest.